People In The News | GenomeWeb

NEW YORK (GenomeWeb) – The New York Genome Center has named Harold Swerdlow its VP of Technology Innovation.

In the role, he will be responsible for developing technologies to be used in genomics research and in clinical applications, including microfluidic tools for reducing the cost of single-cell and other DNA preparation methods for next-generation sequencing.

Swerdlow formerly was head of R&D at the Wellcome Trust Sanger Institute, he formerly was chief technology officer at Dolomite, and he was senior director of research at Solexa.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.